Integrum AB announces changes to management team

Dr. Max Ortiz Catalan is becoming the head of the new Bionics research unit at Chalmers University of Technology. This new research unit will investigate advanced bionic systems such as the highly integrated prosthetic technologies embodied by the e-OPRA Implant System. Dr Ortiz Catalan will leave Integrum’s management team to dedicate more of his time to this new challenge. However, he will continue working closely with the company, as a Research Advisor, in the development of the next generation of Integrum's implant and prosthetics technologies.

“I would like to express my gratitude to Max Ortiz Catalan for his support and contribution to the success of Integrum during these years as part of our management team and wish him and his team the best at the Bionics research group” said Maria López, CEO at Integrum

For more information, please contact:

María López, CEO. Cell: +46 708 46 10 69, Email: maria.lopez@integrum.se

Certified Adviser

Erik Penser Bank AB, Certified Adviser can be reached at +46 8 463 8000 or certifiedadviser@penser.se

Integrum provides innovative solutions for bone-anchored prostheses. Integrum’s OPRA implant system improves quality of life for amputees through higher prosthetic functionality, improved comfort and improved mobility. With 20 years’ experience from 500 surgeries in 14 countries, Integrum has today a leading position in bone anchored protheses. The company is publicly listed at Nasdaq Firth North Market.